Status:
NOT_YET_RECRUITING
Continuous Erector Spinae Block for Analgesia Following Lumbar Decompression
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Lumbar Spinal Stenosis
Lumbar Radiculopathy
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Lumbar spinal surgery is common, and the incidence of spinal fusion has increased dramatically over the past three decades. Patients requiring spinal surgery are typically prescribed several analgesic...
Detailed Description
Hypothesis Our hypothesis is that a continuous erector spinae plane block (cESP) is an effective postoperative analgesia for lumbar decompression and interbody fusion patients. Primary Study Objectiv...
Eligibility Criteria
Inclusion
- Adult (aged \>18 years) patients
- Undergoing lumbar decompression surgery +/- fusion
- Under the orthopedic surgery team
Exclusion
- Surgery on an emergency basis (level 1, 2 or 3; \<8 hours)
- An ejection fraction \<30%
- Severe pre-existing liver disease (Child B or C)
- Severe kidney disease (Glomerular filtration rate (GFR) \<30 (mL/min/1·73m²))
- An allergy to ropivacaine
- Weight \<50 kg
- Unable to provide valid consent to study prior to surgery
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06987409
Start Date
December 1 2025
End Date
August 1 2027
Last Update
May 23 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.